Aquestive Therapeutics (AQST)
(Delayed Data from NSDQ)
$2.88 USD
-0.03 (-1.03%)
Updated May 31, 2024 04:00 PM ET
After-Market: $2.90 +0.02 (0.69%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/05/2024
Time: -- |
6/2024 | $-0.10 | -8.19% |
Earnings Summary
For their last quarter, Aquestive Therapeutics (AQST) reported earnings of -$0.17 per share, missing the Zacks Consensus Estimate of -$0.09 per share. This reflects a negative earnings surprise of 88.89%. Look out for AQST's next earnings release expected on August 05, 2024. For the next earning release, we expect the company to report earnings of -$0.10 per share, reflecting no change in earnings compared to the year-ago quarter.
Earnings History
Price & Consensus
Zacks News for AQST
Compared to Estimates, Aquestive Therapeutics (AQST) Q1 Earnings: A Look at Key Metrics
AQST: What are Zacks experts saying now?
Zacks Private Portfolio Services